HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reanalysis of a Phase 3 Trial of a Monthly Extended-Release Risperidone Injection for the Treatment of Acute Schizophrenia.

AuthorsAnne Le Moigne, Maurizio Fava, John Csernansky, John W Newcomer, James Graham
JournalJournal of clinical psychopharmacology (J Clin Psychopharmacol) 2021 Jan-Feb 01 Vol. 41 Issue 1 Pg. 76-77 ISSN: 1533-712X [Electronic] United States
PMID33208710 (Publication Type: Clinical Trial, Phase III, Letter, Randomized Controlled Trial)
Chemical References
  • Antipsychotic Agents
  • Delayed-Action Preparations
  • Risperidone
Topics
  • Adolescent
  • Adult
  • Antipsychotic Agents (administration & dosage)
  • Delayed-Action Preparations
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Risperidone (administration & dosage)
  • Schizophrenia (drug therapy, physiopathology)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: